Ceribell (CBLL) Income from Continuing Operations (2023 - 2026)
Ceribell (CBLL) posted Income from Continuing Operations of 19737000.0 for Q1 2026, down 45.91% on a QoQ basis from 13527000.0 in Q4 2025, and down 54.47% year-over-year from 43352183.08 in Q1 2025.
Ceribell (CBLL) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Ceribell's Income from Continuing Operations history runs 4 years deep, the most recent figure standing at 19737000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 54.47% year-over-year to 19737000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 60372000.0 (down 35.03% YoY) and the FY2025 annual result came in at 53971000.0, down 69.15% from the prior year.
- Income from Continuing Operations was 19737000.0 for Q1 2026 at Ceribell, down from 13527000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 7054000.0 in Q3 2023 and bottomed at 19737000.0 in Q1 2026.
- A 4-year average of 11721090.91 and a median of 12576000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations fell 7.56% — and 2026, when it slumped 54.47%.
- Ceribell's Income from Continuing Operations stood at 8274000.0 in 2023, then tumbled by 51.99% to 12576000.0 in 2024, then dropped by 7.56% to 13527000.0 in 2025, then plunged by 45.91% to 19737000.0 in 2026.
- Business Quant data shows CBLL's Income from Continuing Operations at 19737000.0 in Q1 2026, 13527000.0 in Q4 2025, and 13465000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | -19.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.74 Mn |
| Dec 31, 2025 | -13.53 Mn |
| Sep 30, 2025 | -13.47 Mn |
| Jun 30, 2025 | -13.64 Mn |
| Mar 31, 2025 | -12.78 Mn |
| Dec 31, 2024 | -12.58 Mn |
| Sep 30, 2024 | -10.42 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -8.52 Mn |
| Dec 31, 2023 | -8.27 Mn |
| Sep 30, 2023 | -7.05 Mn |